MAPPI: Market Access Potential and Price Index

groupH has developed MAPPI to enable the evaluation of market access potential, and its impact on investment decisions and NPV valuations.

MAPPI is free to use and can be used multiple times for: screening of investments, course correction during development, optimizing positioning, or supporting Business Development activities.

Invio Logo

For information on the MAPPI tool please refer to our article: Projecting Market Access Success For Early-Stage Pharma Assets: Getting Past The Hurdles. Nicolas Touchot, Lynn Nishida, Mathias Flume. In Vivo. February 2013. For further details and additional papers from Nicolas on the subject of Market Access, please visit our Inspiration article